Methysergide-induced retroperitoneal fibrosis: Successful outcome and two new laboratory features

被引：9

作者：

Bucci, JA ^{[1
]}

Manoharan, A ^{[1
]}

机构：

[1] ST GEORGE HOSP,DEPT CLIN HAEMATOL,SYDNEY,NSW,AUSTRALIA

来源：

MAYO CLINIC PROCEEDINGS | 1997年 / 72卷 / 12期

关键词：

D O I：

10.4065/72.12.1148

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 25-year-old woman sought medical attention because of iliocaval manifestations of retroperitoneal fibrosis while she was taking methysergide. Laboratory studies yielded substantially increased serum procollagen In levels and anticardiolipin antibodies accompanied with anti-beta(2) glycoprotein I, findings not previously described with this disorder, Clinical and laboratory manifestations resolved after cessation of methysergide therapy.

引用

页码：1148 / 1150

页数：3

共 15 条

[11]

Ramakrishna R, 1995, PATHOLOGY, V27, P255

[12] ILIOCAVAL COMPLICATIONS OF RETROPERITONEAL FIBROSIS [J].

RHEE, RY ;

GLOVICZKI, P ;

LUTHRA, HS ;

STANSON, AW ;

BOWER, TC ;

CHERRY, KJ .

AMERICAN JOURNAL OF SURGERY, 1994, 168 (02) :179-183

[13] ASSOCIATION OF ANTI-BETA-2 GLYCOPROTEIN-I ANTIBODIES WITH LUPUS-TYPE CIRCULATING ANTICOAGULANT AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

VIARD, JP ;

AMOURA, Z ;

BACH, JF .

AMERICAN JOURNAL OF MEDICINE, 1992, 93 (02) :181-186

[14] RETROPERITONEAL FIBROSIS ACCOMPANYING IMMUNE THROMBOCYTOPENIA [J].

WALLACH, PM ;

FLANNERY, MT ;

ADELMAN, HM ;

POWSANG, J ;

SABA, H ;

ALTUS, P ;

ESPINOZA, LR .

AMERICAN JOURNAL OF HEMATOLOGY, 1991, 37 (03) :204-205

[15]

WANG MX, 1995, J IMMUNOL, V155, P1629

← 1 2 →